{"id":"F2013L00772","name":"Therapeutic Goods (Listing) Notice 2013 (No. 1)","slug":"therapeutic-goods-listing-notice-2013-no-1","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":90476,"registerId":"commonwealth-F2013L00772-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2013 (No. 1)","content":"Therapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2013 (No. 1)\n\nI, JOHN SKERRITT, National Manager of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:\n\n-   preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘concentrated omega-3-triglycerides - squid’ as a therapeutically active ingredient, subject to the following conditions:\n\n-   the preparations are for oral use only; and\n-   the ‘concentrated omega-3\\-triglycerides - squid’ is obtained from species of the order Teuthida of the class Cephalopoda; and\n-   the ‘concentrated omega-3-triglycerides - squid’ is in combination with other ingredients; and\n-   the preparations are presented in a therapeutic dosage form for therapeutic use; and\n-   the container, and any other packaging for the goods, is labelled with the warning –\n    -   “DERIVED FROM SEAFOOD”.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.\n\nDated this 10th day of May 2013\n\n(Signed by)\n\nJohn Skerritt\n\nDelegate of the Minister for Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1768},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The notice performs exactly its narrow statutory function under section 9A(5) of the Act—temporarily listing a specific therapeutic ingredient pending permanent inclusion in the Regulations. It has not expanded beyond this discrete administrative purpose."},"complexity_factors":["Single specific ingredient with precise biological classification (order Teuthida, class Cephalopoda)","Five cumulative conditions that must all be satisfied simultaneously","Temporary legislative mechanism requiring understanding of the interplay between subsection 9A(5) (temporary listing) and subsection 9A(6) (automatic cessation upon regulatory amendment)","Reference to specific Schedule item (Item 3 of Part 1 of Schedule 4 to the Regulations) without reproducing that text"],"plain_english_summary":"This notice allows specific **squid-based omega-3 supplements** to be legally sold in Australia by listing them on the Australian Register of Therapeutic Goods (ARTG).\n\n**What it covers:**\n- Oral preparations containing \"concentrated omega-3-triglycerides - squid\" as an active ingredient\n- The squid oil must come from species in the order **Teuthida** (a specific biological classification)\n- The ingredient must be combined with other substances (not sold alone)\n- Must be presented as a therapeutic product (e.g., capsules, tablets)\n\n**Key requirements:**\n- **For oral use only** (not injections or topical creams)\n- **Mandatory warning label:** The packaging must display \"DERIVED FROM SEAFOOD\"\n\n**Important caveat:** This is a **temporary approval**. The notice only stays in effect until the Therapeutic Goods Regulations are formally updated to permanently include these squid omega-3 products in the Register. This mechanism allows the products to enter the market immediately rather than waiting for the slower regulation-making process."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2013-no-1","history":"/api/acts/therapeutic-goods-listing-notice-2013-no-1/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2013-no-1/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2013-no-1/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2013-no-1/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2013-no-1/documents"}}